Key Highlights
•
A new study introduces “shooting-free days” as a four-tiered metric to track gun violence across 10 major U.S. cities. This new measurement tool provides a more nuanced way for public health officials and policymakers to monitor trends and evaluate the effectiveness of violence prevention programs.
Source →
•
For the first time in over three years, global health organizations have announced that the supply of oral cholera vaccine is now adequate to resume preventive vaccination campaigns. This is a critical step in controlling outbreaks of the deadly diarrheal disease, especially in vulnerable communities with limited clean water and sanitation.
Source →
•
A national study finds that children exposed to neighborhood violence are significantly more likely to have delayed or missed medical, dental, and mental health care due to cost. This highlights a major gap in healthcare access, suggesting that improving health coverage and financial support is essential to protect the well-being of vulnerable children.
Source →
•
A therapy that combines exposure-based cognitive behavioral techniques with intensive community support teams significantly reduced anxiety and improved quality of life for people with severe mental illnesses. This shows that integrating simple psychological tools into existing outreach services is a feasible and effective way to address a common but often overlooked problem.
Source →
•
A new, adjusted dose of the COVID-19 antiviral drug nirmatrelvir/ritonavir (Paxlovid) was found to be safe and effective for patients with severe kidney disease who require dialysis. This provides a crucial treatment option for a high-risk group that was previously excluded from using this medication due to safety concerns.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
